[Action of ET 495 (1-(2"-pyrimidyl) 4-(methylene 3',4'-dioxy benzyl) piperazine) on the muscle and cutaneous circulation of the anesthetized dog].
D000818:Animals; D001593:Benzyl Compounds / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D003097:Collateral Circulation / Q000187:drug effects; D004149:Dioxoles / Q000494:pharmacology; D004285:Dogs; D005263:Femoral Artery; D008026:Ligation; D009132:Muscles / Q000098:blood supply*; D010879:Piperazines / Q000494:pharmacology*; D011743:Pyrimidines / Q000494:pharmacology; D012039:Regional Blood Flow / Q000187:drug effects*; D012867:Skin / Q000098:blood supply*; D013268:Stimulation, Chemical; D014655:Vascular Resistance / Q000187:drug effects; D014665:Vasodilator Agents / Q000494:pharmacology*
D001593:Benzyl Compounds; D004149:Dioxoles; D010879:Piperazines; D011743:Pyrimidines; D014665:Vasodilator Agents
Action du ET 495 ((pyrimidyl-2")-1 (méthylene dioxy-3',4' benzyl)-4 pipérazine) sur la circulation musculaire et cutanée du chien anesthésié.